Wikidata

(Q53535574)

English

Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: a multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08.

scientific article published on 16 April 2015

In more languages

Statements

title
Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: a multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08 (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25892646
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25892646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53535574&oldid=1471922070"